EN DE
STOCK COMPARISON

Doximity vs Veeva Systems Inc Class A: Fair Value & Quality

Both stocks run through our valuation models. Here is how Doximity (DOCS) and Veeva Systems Inc Class A (VEEV) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Doximity as the less overvalued of the two: Doximity trades at $27.40 versus a fair value of $17.18 (-37%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).
Doximity
DOCS · USD · Health Care
-37%
upside to fair value
overvalued
Price$27.40
Fair Value$17.18
Quality89/100
Veeva Systems Inc Class A
VEEV · USD · Health Care
-59%
upside to fair value
overvalued
Price$230
Fair Value$95.12
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

DoximityVeeva Systems Inc Class A
Valuation
22.7×P/E (TTM)33.6×
6.31×P/S (TTM)9.31×
4.28×P/B4.28×
16.8×EV/EBITDA28.7×
0.59×PEG0.85×
Profitability
30%Net margin28%
22%Operating margin31%
19%Return on equity14%
12%Return on assets7%
Growth
5%Revenue growth (YoY)16%
15.5%Avg. growth/yr (3Y)14.0%
25.5%Avg. growth/yr (5Y)16.9%
Balance & size
$4BMarket cap$31B
healthyGrowth qualityhealthy

Doximity leads: 9 to 2 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Doximityof which business quality 87 · market factors 18 Veeva Systems Inc Class Aof which business quality 72 · market factors 48
ProfitabilityMargins and returns on capital today
80
57
Quality GrowthAre margins and returns improving?
57
65
CashflowEarnings quality: real cash, not paper profit
94
93
Fin. StrengthBalance sheet, leverage, solvency risk
93
91
InvestmentDisciplined investing over empire-building
100
33
Low VolatilityCalm price path (market factor)
20
55
MomentumPrice trend over the last 3–12 months (market factor)
23
52
52W MomentumDistance to the 52-week high (market factor)
9
31
Net IssuanceBuybacks instead of dilution
95
72

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Doximity

DCF Models$54.43
Earnings-Based$35.88
Multiples$25.62
Asset-Based$4.83
Growth DCF$50.74
Economic Profit$17.66
Growth Earnings$47.37

8 of 24 models see the stock below the current price.

Veeva Systems Inc Class A

DCF Models$214
Earnings-Based$142
Dividend Discount$0.41
Multiples$93.60
Asset-Based$29.76
Growth DCF$200
Economic Profit$57.47
Growth Earnings$185

21 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Doximity
Bear $13.15Fair Value $17.18Bull $21.21
$27.40 = current price (white tick)
Veeva Systems Inc Class A
Bear $71.34Fair Value $95.12Bull $146
$230 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Doximity · Health Care

Quality score89 · Top 25%
Fair value upside-37% · below median

Veeva Systems Inc Class A · Health Care

Quality score72 · Top 25%
Fair value upside-59% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Doximity as the less overvalued of the two: Doximity trades at $27.40 versus a fair value of $17.18 (-37%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).

Doximity has the higher quality score (89/100).

See the full analysis →
Doximity · Veeva Systems Inc Class A

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Doximity

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Veeva Systems Inc Class A

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.